Edgewise Therapeutics, Inc.

NasdaqGS:EWTX Stock Report

Market Cap: US$1.8b

Edgewise Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

Edgewise Therapeutics has a total shareholder equity of $318.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $340.0M and $21.2M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$318.39m
EquityUS$318.83m
Total liabilitiesUS$21.21m
Total assetsUS$340.04m

Recent financial health updates

Recent updates

Edgewise Therapeutics: Behind The Massive Rally

Feb 18

Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Dec 07
Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans

Aug 16
Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans

Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Apr 28
Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Jan 13
We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Edgewise Therapeutics proposes $100M stock offering plan

Sep 13

Edgewise Therapeutics GAAP EPS of -$0.32 beats by $0.02

Aug 04

Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Aug 02
Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

Nov 23
We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

Edgewise Therapeutics names new chief medical officer

Apr 27

Financial Position Analysis

Short Term Liabilities: EWTX's short term assets ($327.0M) exceed its short term liabilities ($16.8M).

Long Term Liabilities: EWTX's short term assets ($327.0M) exceed its long term liabilities ($4.4M).


Debt to Equity History and Analysis

Debt Level: EWTX is debt free.

Reducing Debt: EWTX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EWTX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: EWTX has sufficient cash runway for 2.8 years if free cash flow continues to reduce at historical rates of 49.7% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.